Baxter International is a medical instruments & supplies business based in the US. Baxter International shares (BAX) are listed on the NYSE and all prices are listed in US Dollars. Baxter International employs 60,000 staff and has a trailing 12-month revenue of around $14.9 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $35.09 |
|---|---|
| 52-week range | $30.28 - $47.80 |
| 50-day moving average | $34.23 |
| 200-day moving average | $37.38 |
| Wall St. target price | $41.92 |
| PE ratio | N/A |
| Dividend yield | $1.16 (3.28%) |
| Earnings per share (TTM) | $-0.08 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $35.09 from 2024-07-25
| 1 week (2024-07-19) | -0.74% |
|---|---|
| 1 month (2024-06-27) | 4.68% |
| 3 months (2024-04-26) | -12.56% |
| 6 months (2024-01-26) | -9.54% |
| 1 year (2023-07-27) | -22.85% |
|---|---|
| 2 years (2022-07-27) | -47.47% |
| 3 years (2021-07-27) | 82.11 |
| 5 years (2019-07-26) | 83.2081 |
Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Baxter International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6956. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Baxter International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Baxter International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.9 billion.
The EBITDA is a measure of a Baxter International's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $14.9 billion |
|---|---|
| Operating margin TTM | 10.05% |
| Gross profit TTM | $6 billion |
| Return on assets TTM | 3.54% |
| Return on equity TTM | -0.42% |
| Profit margin | 17.79% |
| Book value | $16.04 |
| Market Capitalization | $18 billion |
TTM: trailing 12 months
Dividend payout ratio: 42.03% of net profits
Recently Baxter International has paid out, on average, around 42.03% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.28% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 3.28% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $1.16 per share.
While Baxter International's payout ratio might seem fairly standard, it's worth remembering that Baxter International may be investing much of the rest of its net profits in future growth.
Baxter International's most recent dividend payout was on 30 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 29 August 2024 (the "ex-dividend date").
Baxter International's shares were split on a 1841:1000 basis on 30 June 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.
Over the last 12 months, Baxter International's shares have ranged in value from as little as $30.2832 up to $47.8023. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.574. This would suggest that Baxter International's shares are less volatile than average (for this exchange).
Baxter International Inc. , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.
Learn how to invest in Cathie Wood’s ARK Venture Fund in 5 easy steps.
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.